In this chapter,

(1) “assessable entity” means

(A) a health care insurer as defined in AS 21.54.500;

(B) an entity that provides the state health care plan described in AS 39.30.090 and 39.30.091;

(C) a public or private entity that offers a publicly funded plan in the state, to the extent participation in the program is authorized by law;

(D) a third-party administrator as defined in AS 21.97.900;

(2) “commission” means the Alaska Health Care Commission established in AS 18.09.010;

(3) “commissioner” means the commissioner of health and social services;

(4) “council” means the State Vaccine Assessment Council;

(5) “covered individual” means an adult or child who resides in the state and who is provided insurance coverage for an included vaccine by an assessable entity or who is a patient of another program participant;

(6) “department” means the Department of Health and Social Services.

(7) “included vaccine” means a vaccine recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention, United States Department of Health and Human Services, and included on a list maintained by the commissioner for inclusion in the program;

(8) “other program participant” and “another program participant” mean a health care provider or group of providers who have opted into the program under AS 18.09.225 to both purchase vaccines for and administer vaccinations to residents of the state;

(9) “program” means the statewide immunization program;

(10) “provider” means a person licensed or certified by the state to administer vaccines or provide health care services or a partnership, corporation, or other entity made up of persons licensed or certified to administer vaccines or provide health care services;

(11) “vaccine” means a preparation of killed microorganisms, living attenuated organisms, living fully virulent organisms, or other substances that are administered to humans for the purpose of producing or artificially increasing specific immunity to life-threatening and disabling diseases.